December 12, 2024 FAQ: Gilead’s LENACAPAVIR (LEN-LA) license and implications for access Educational Material, Fair Access, Gilead License
December 2, 2024 Activist Coalition Demands Accelerated Access to Revolutionary HIV Prevention Fair Access, Gilead License, News & Opinions